United States · FDA National Drug Code directory
Fenofibrate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43975-305_379ca6d7-14ee-4c36-a271-325d231a2fba
- Product NDC
- 43975-305
- Form
- CAPSULE
- Composition / generic term
- Fenofibrate
- Labeler
- ANI Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180501
- Source listing expiry
- 20261231
Source-listed ingredients
- FENOFIBRATE — 134 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (43975-305-10) · 43975-305-10
- 500 CAPSULE in 1 BOTTLE (43975-305-50) · 43975-305-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →